Loading clinical trials...

Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD) | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT06638879

Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)

This study aims to investigate the use of a novel formulation of tacrolimus, as a toothpaste, in a population of patients with oral chronic graft vs. host disease (cGVHD) as an adjunctive therapy in a...

Lead sponsor: Children's Hospital Medical Center, Cincinnati•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment7

Start dateSep 2024

Last updatedMar 6, 2026

Condition

Chronic Graft Versus Host Disease Oral

Locations shown

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 6, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions